Evidence for a telomere-independent 'clock' limiting RAS oncogene-driven proliferation of human thyroid epithelial cells

Molecular and Cellular Biology

Volumn 20, Issue 15, 2000, Pages 5690-5699

  Jones, C J ^a   Kipling, D ^a   Morris, M ^a   Hepburn, P ^a   Skinner, J ^a   Bounacer, A ^a   Wyllie, F S ^a   Ivan, M ^a   Bartek, J ^b   Wynford Thomas, D ^a   Bond, J A ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; ENZYME ACTIVITY; EPITHELIUM CELL; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; ONCOGENE RAS; PRIORITY JOURNAL; TELOMERE; THYROID CELL;

CATALYTIC DOMAIN; CELL DIVISION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; EPITHELIAL CELLS; HUMANS; MICROFILAMENT PROTEINS; MUSCLE PROTEINS; MUTATION; ONCOGENE PROTEINS, VIRAL; RAS PROTEINS; TELOMERE; THYROID GLAND;

EID: 0033941559     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.15.5690-5699.2000     Document Type: Article

References (73)

1. Almoguera, C., D. Shibata, K. Forrester, J. Martin, N. Arnheim, and M. Perucho. 1988. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53:549-554.
2. Bartkova, J., J. Lukas, M. Strauss, and J. Bartek. 1998. Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation. Oncogene 17:1027-1037.
3. Bodnar, A. G., M. Ouellette, M. Frolkis, S. E. Holt, C.-P. Chiu, G. B. Morin, C. B. Harley, J. W. Shay, S. Lichtsteiner, and W. E. Wright. 1998. Extension of life-span hy introduction of telomerase into normal human cells. Science 279:349-352.
4. Bond, J., M. Haughton, J. Rowson, V. Gire, D. Wynford-Thomas, and F. Wyllie. 1999. Control of replicative life span in human cells: barriers to clonal expansion intermediate between M1 senescence and M2 crisis. Mol. Cell. Biol. 19:3103-3114.
5. Bond, J. A., F. S. Wyllie, and D. Wynford-Thomas. 1994. Escape from senescence in human diploid fibroblasts induced directly by mutant p53. Oncogene 9:1885-1889.
6. Bond, J. A., G. O. Ness, J. Rowson, M. Ivan, D. White, and D. Wynford-Thomas. 1996. Spontaneous de-differentiation correlates with extended lifes-pan in transformed thyroid epithelial cells: an epigenetic mechanism of tumour progression. Int. J. Cancer 67:563-572.
7. Bond, J. A., F. S. Wyllie, J. Rowson, A. Radulescu, and D. Wynford-Thomas. 1994. In vitro reconstruction of tumour initiation in a human epithelium. Oncogene 9:281-290.
8. Bos, J. L., E. R. Fearon, S. R. Hamilton, M. Verlaan-de Vries, J. H. van Boom, A. J. van der Eb, and B. Vogelstein. 1987. Prevalence of ras gene mutations in human colorectal cancers. Nature 327:293-297.
9. Bos, J. L. 1989. Ras oncogenes in human cancer: a review. Cancer Res. 49:4682-4689.
10. Broccoli, D., J. W. Young, and T. de Lange. 1995. Telomerase activity in normal and malignant hematopoietic cells. Proc. Natl. Acad. Sci. USA 92: 9082-9086.
11. Brown, J. P., W. Wenyi, and J. M. Sedivy. 1997. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 277:831-834.
12. Cheng, M., P. Olivier, J. A. Diehl, M. Fero, M. F. Roussel, J. M. Roberts, and C. J. Sherr. 1999. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18:1571-1583.
13. Coppee, F., F. Depoortere, J. Bartek, C. Ledent, M. Parmentier, and J. E. Dumont. 1998. Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours. Oncogene 17:631-641.
14. Depoortere, F., A. Van Keymeulen, J. Lukas, S. Costagliola, J. Bartkova, J. E. Dumont, J. Bartek, P. P. Roger, and S. Dremier. 1998. A requirement for cyclin D3-cyclin-dependent kinase (cdk)-4 assembly in the cyclic adenosine monophosphate-dependent proliferation of thyrocytes. J. Cell Biol. 140: 1427-1439.
15. Dimri, G. P., X. Lee, G. Basile, M. Acosta, G. Scott, C. Roskelley, E. E. Medrano, M. Linskens, I. Rubelj, O. Pereira-Smith, M. Peacocke, and J. Campisi. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92:9363-9367.
16. Durand, B., M. L. Fero, J. M. Roberts, and M. C. Raff. 1998. p27Kip1 alters the response of cells to mitogen and is part of a cell-intrinsic timer that arrests the cell cycle and initiates differentiation. Curr. Biol. 8:431-440.
17. Erickson, L. A., L. Jin, P. C. Wollan, G. B. Thompson, J. van Heerden, and R. V. Lloyd. 1998. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors. Mod. Pathol. 11:169-174.
18. Fearon, E. R., and B. Vogelstein. 1990. A genetic model for colorectal tumorigenesis. Cell 61:759-767.
19. Fero, M. L., M. Rivkin, M. Tasch, P. Porter, C. E. Carow, E. Firpo, K. Polyak, L. H. Tsai, V. Broudy, R. M. Perlmutter, K. Kaushansky, and J. M. Roberts. 1996. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85:733-744.
20. Foster, S. A., D. J. Wong, M. T. Barrett, and D. A. Galloway. 1998. Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol. Cell. Biol. 18:1793-1801.
21. Gire, V., and D. Wynford-Thomas. 1998. Reinitiation of DNA synthesis and cell division in senescent human fibroblasts by microinjection of anti-p53 antibodies. Mol. Cell. Biol. 18:1611-1621.
22. Gire, V., C. J. Marshall, and D. Wynford-Thomas. 1999. Activation of mitogen-activated protein kinase is necessary but not sufficient for proliferation of human thyroid epithelial cells induced by mutant Ras. Oncogene 18:4819-4832.
23. Hirai, A., S. Nakamura, Y. Noguchi, T. Yasuda, M. Kitagawa, I. Tatsuno, T. Oeda, K. Tahara, T. Terano, S. Narumiya, L. D. Kohn, and Y. Saito. 1997 Geranylgeranylated rho small GTPase(s) are essential for the degradation of p27Kip1 and facilitate the progression from G1 to S phase in growth-stimulated rat FRTL-5 cells. J. Biol. Chem. 272:13-16.
24. Holliday, R. 1996. Endless quest. Bioessays 18:3-5.
25. Hu, W., C. J. Bellone, and J. J. Baldassare. 1999. RhoA stimulates p27(Kip) degradation through its regulation of cyclin E/CDK2 activity. J. Biol. Chem. 274:3396-3401.
26. Huschtscha, L. I., J. R. Noble, A. A. Neumann, E. L. Moy, P. Barry, J. R. Melki, S. J. Clark, and R. R. Reddel. 1998. Loss of p16INK4 expression by methylation is associated with lifespan extension of human mammary epithelial cells. Cancer Res. 58:3508-3512.
27. Ivan, M., D. Wynford-Thomas, and C. J. Jones. 1996. Abnormalities of the p16INK4a gene in thyroid cancer cell lines. Eur. J. Cancer 32:2369-2370.
28. Jacobs, J., K. Kieboom, S. Marino, R. de Pinho, and M. van Lohuizen. 1999. The oncogene and polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397:164-168.
29. Jones, C. J., J. J. Shaw, F. S. Wyllie, N. Gaillard, M. Schlumberger, and D. Wynford-Thomas. 1996. High frequency deletion of the tumour suppressor gene P16INK4a (MTS1) in human thyroid cancer cell lines. Mol. Cell. Endocrinol. 116:115-119.
30. Jones, C. J., A. Soley, J. W. Skinner, J. Gupta, M. F. Haughton, F. S. Wyllie, M. Schlumberger, S. Bacchetti, and D. Wynford-Thomas. 1998. Dissociation of telomere dynamics from telomerase activity in human thyroid cancer cells. Exp. Cell Res. 240:333-339.
31. Kawada, M., S. Yamagoe, Y. Murakami, K. Suzuki, S. Mizuno, and Y. Uehara. 1997. Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway. Oncogene 15:629-637.
32. Kim, N. W., M. A. Piatyszek, K. R. Prowse, C. B. Harley, M. D. West, P. L. C. Ho, G. M. Coviello, W. E. Wright, S. L. Weinrich, and J. W. Shay. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015.
33. Kiyokawa, H., R. D. Kineman, K. O. Manova-Todorova, V. C. Soares, E. S. Hoffman, M. Ono, D. Khanam, A. C. Hayday, L. A. Frohman, and A. Koff. 1996. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85:721-732.
34. Kiyono, T., S. A. Foster, J. I. Koop, J. K. McDougall, D. A. Galloway, and A. J. Klingelhutz. 1998. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396:84-88.
35. Kruk, P. A., N. J. Rampino, and V. A. Bohr. 1995. DNA damage and repair in telomeres: relation to aging. Proc. Natl. Acad. Sci. USA 92:258-262.
36. Lemoine, N. R., E. S. Mayall, F. S. Wyllie, E. D. Williams, M. Goyns, B. Stringer, and D. Wynford-Thomas. 1989. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene 4:159-164.
37. Lemoine, N. R., S. Staddon, J. Bond, F. S. Wyllie, J. J. Shaw, and D. Wynford-Thomas. 1990. Partial transformation of human thyroid epithelial cells by mutant Ha-ras oncogene. Oncogene 5:1833-1837.
38. Leone, G., J. DeGregori, R. Sears, L. Jakoi, and J. R. Nevins. 1997. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature 387:422-426.
39. Lin, A. W., M. Barradas, J. C. Stone, L. van Aelst, M. Serrano, and S. W. Lowe. 1998, Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12: 3008-3019.
40. Lloyd, A. C. 1998. Ras versus cyclin-dependent kinase inhibitors. Curr. Opin. Genet. Dev 8:43-48.
41. Lloyd, R. V., L. Jin, X. Qian, and E. Kulig. 1997. Aberrant p27kip1 expression in endocrine and other tumors. Am. J. Pathol. 150:401-407.
42. Lloyd, R. V., L. A. Erickson, L. Jin, E. Kulig, X. Qian, J. C. Cheville, and B. W. Scheithauer. 1999. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am. J. Pathol. 154: 313-323.
43. Lukas, J., D. Parry, L. Aagaard, D. J. Mann, J. Bartkova, M. Strauss, G. Peters, and J. Bartek. 1995. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375:503-506.
44. Lukas, J., C. S. Sorensen, C. Lukas, E. Santoni-Rugiu, and J. Bartek. 1999. p16INK4a, but not constitulively active pRb, can impose a sustained G1 arrest; molecular mechanisms and implications for oncogenesis. Oncogene 18:3930-3935.
45. INK4a. Mol. Cell. Biol. 19:3916-3928.
46. Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587-3596.
47. Nakayama, K., N. Ishida, M. Shirane, A. Inomata, T. Inoue, N. Shishido, I. Horii, and D. Y. Loh. 1996. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707-720.
48. Olson, M. F., H. F. Paterson, and C. J. Marshall. 1998. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1. Nature 394: 295-299.
49. Onishi, T., and K. Hruska. 1997. Expression of p27Kip1 in osteoblast-like cells during differentiation with parathyroid hormone. Endocrinology 138: 1995-2004.
50. Pagano, M., S. W. Tam, A. M. Theodoras, P. Beer-Romero, G. Del Sal, V. Chau, P. R. Yew, G. F. Draetta, and M. Rolfe. 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682-685.
51. Palmero, I., C. Pantoja, and M. Serrano. 1998. p19ARF links the tumour suppressor p53 to Ras. Nature 395:125-126.
52. Reddel, R. 1998. A reassessment of the telomere hypothesis of senescence. Bioessays 20:977-984.
53. Reznikoff, C. A., T. R. Yeager, C. D. Belair, E. Savelieva, J. A. Puthenveettil, and W. M. Stadler. 1996, Hlevaled p16 at senescence and loss of 16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells. Cancer Res. 56:2886-2890.
54. Russo, I., A. R. Silver, A. P. Cuthbert, D. K. Griffin, D. A. Trott, and R. F. Newbold. 1998. A telomere-independent senescence mechanism is the sole barrier to Syrian hamster cell immortalization. Oncogene 17:3417-3426.
55. Serrano, M., A. W. Lin, M. E. McCurrach, D. Beach, and S. W. Lowe. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593-602.
56. Sheaff, R. J., M. Groudine, M. Gordon, J. M. Roberts, and B. E. Clurman. 1997. Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev. 11:1464-1478.
57. Sherr, C. J., and J. M. Roberts. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1501-1512.
58. Suarez, H. G., J. A. du Villard, M. Severino, B. Caillou, M. Schlumberger, M. Tubiana, C. Parmentier, and R. Monier. 1990. Presence of mutations of all three ras genes in human thyroid tumours. Oncogene 5:565-570.
59. kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts. Mol. Cell. Biol. 17:5348-5358.
60. Tallini, G., G. Garcia-Rostan, A. Herrero, D. Zelterman, G. Viale, S. Bosari, and M. L. Carcangiu. 1999. Downregulation of p27KIP1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories. Am. J. Surg. Pathol. 23:678-685.
61. Tsvetkov. L. M., K. H. Yen, S. J. Lee, H. Sun, and H. Zhang. 1999. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr. Biol. 9:661-664.
62. Vlach, J., S. Hennecke, and B. Amati. 1997. Phosphorylation-dependent degradation of thecyclin-dependent kinase inhibitor p27. EMBO J. 16:5334-5344.
63. Wang, S., J. Wuu, L. Savas, N. Patwardhan, and A. Khan. 1998. The role of cell cycle regulatory proteins, cyclin D1, cyclin E, and p27 in thyroid carcinogencsis. Hum. Pathol. 29:1304-1309.
64. Weber, J. D., W. Hu, S. C. Jefcoat, Jr., D. M. Raben, J. J. Baldassare. 1997. Ras-stimulated extracellular signal-related kinase 1 and RhoA activities coordinate platelet-derived growth factor-induced G1 progression through the independent regulation of cyclin D1 and p27. J. Biol. Chem. 272:32966-32971.
65. Wei, S., and J. M. Sedivy. 1999. Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts. Cancer Res. 59:1539-1543.
66. Williams, D. W., E. D. Williams, and D. Wynford-Thomas. 1988. Loss of dependence in IGF-1 for proliferation of human thyroid adenoma cells. Br. J. Cancer 57:535-539.
67. Wright, W. E., J. W. Shay, and M. A. Piatyszek. 1995. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res. 23:3794-3795.
68. Wyllie, F. S., C. J. Jones, J. W. Skinner, M. F. Haughton, C. Wallis, D. Wynford-Thomas, R. G. Faragher, and D. Kipling. 2000. Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts. Nat. Genet. 24: 16-17.
69. Wynford-Thomas, D. 1999. Cellular senescence and cancer. J. Pathol. 187: 100-111.
70. Wynford-Thomas, D. 1999. Molecular basis of tumour initiation and progression in the thyroid follicular cell: in vitro models, p. 225-238. In G. Thomas, A. Karaoglov, and E. D. Williams (ed.), Radiation and thyroid cancer. World Scientific, London, United Kingdom.
71. Yeager, T. R., S. DeVries, D. F. Jarrard, C. Kao, S. Y. Nakada, T. D. Moon, R. Bruskewitz, W. M. Stadler, L. F. Meisner, K. W. Gilchrist, M. A. Newton, F. M. Waldman, and C. A. Reznikoff. 1998. Overcoming cellular senescence in human cancer pathogenesis. Genes Dev. 12:163-174.
72. Zabludoff, S. D., M. Csete, R. Wagner, X. Yu, and B. J. Wold. 1998. p27Kip1 is expressed transiently in developing myotomes and enhances myogensis. Cell Growth Differ. 9:1-11.
73. Zhu, J., D. Woods, M. McMahon, and J. M. Bishop. 1998. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 12:2997-3007.